StockData
Actuate Therapeutics, Inc. logo

Actuate Therapeutics, Inc. (ACTU) stock

ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.25−0.02 (-6.12%)

Close on Nov 17, 2026Market cap $6.04MP/E –Yield –

Actuate Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Actuate Therapeutics's price to book ratio was 7.3× on Nov 11, 2026, against 16.2× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20267.3×−5.7
2025Dec 31, 202513.0×−16.0
2024Dec 31, 202429.0×–

More Actuate Therapeutics figures

See a number that looks wrong?